hyperammonemia/urea cycle disorders therapeutics (Microbiota Therapeutics)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namehyperammonemia/urea cycle disorders therapeutics (Microbiota Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicrobiome modulators
TargetsUpdating
Therapy Area/IndicationsHyperammonemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMicrobiota Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMicrobiota Therapeutics LLC
Active IndicationsN/A
Inactive IndicationsHyperammonemia

Other Information

ATC CodeN/A
Related LinksN/A